These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11686473

  • 1. Recognition of illness associated with the intentional release of a biologic agent.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Oct 19; 50(41):893-7. PubMed ID: 11686473
    [Abstract] [Full Text] [Related]

  • 2. From the Centers for Disease Control and Prevention. Recognition of illness associated with the intentional release of a biologic agent.
    JAMA; 2001 Nov 07; 286(17):2088-90. PubMed ID: 11757497
    [No Abstract] [Full Text] [Related]

  • 3. Recognition and management of bioterrorism infections.
    O'Brien KK, Higdon ML, Halverson JJ.
    Am Fam Physician; 2003 May 01; 67(9):1927-34. PubMed ID: 12751654
    [Abstract] [Full Text] [Related]

  • 4. Bioterrorism.
    Steinhauer R.
    RN; 2002 Mar 01; 65(3):48-54; quiz 55. PubMed ID: 11961869
    [No Abstract] [Full Text] [Related]

  • 5. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J, Zaki SR.
    J Histochem Cytochem; 2006 Jan 01; 54(1):3-11. PubMed ID: 16148309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bioterrorism syndromes.
    WMJ; 2002 Jan 01; 101(2):13. PubMed ID: 12085490
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism.
    Altman GB.
    Nurs Manage; 2002 Jan 01; 33(1):43, 45-7. PubMed ID: 11984331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA, Broussard LA.
    Expert Rev Mol Diagn; 2003 Sep 01; 3(5):605-16. PubMed ID: 14510181
    [Abstract] [Full Text] [Related]

  • 14. Bioterrorism.
    Bellamy RJ, Freedman AR.
    QJM; 2001 Apr 01; 94(4):227-34. PubMed ID: 11294966
    [No Abstract] [Full Text] [Related]

  • 15. Cutaneous manifestations of category A bioweapons.
    Aquino LL, Wu JJ.
    J Am Acad Dermatol; 2011 Dec 01; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
    [Abstract] [Full Text] [Related]

  • 16. Management of patients exposed to biologic weapons.
    Yetman RJ, Parks D, Taft E.
    J Pediatr Health Care; 2002 Dec 01; 16(5):256-61. PubMed ID: 12226595
    [No Abstract] [Full Text] [Related]

  • 17. Anthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency room.
    Cunha BA.
    Clin Microbiol Infect; 2002 Aug 01; 8(8):489-503. PubMed ID: 12197871
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.
    Cosgrove SE, Perl TM, Song X, Sisson SD.
    Arch Intern Med; 2005 Sep 26; 165(17):2002-6. PubMed ID: 16186470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.